Snap-on (NYSE: SNA) CEO sells 23,396 shares after option exercise
Rhea-AI Filing Summary
Snap-on Inc Chairman, President and CEO Nicholas T. Pinchuk reported an option exercise and related stock sales. He exercised stock options to acquire 33,750 shares of common stock at $168.70 per share, with a portion of the underlying shares sold to cover the exercise price and estimated tax liability under a Rule 10b5-1 Plan adopted on November 3, 2025. On the same date, he executed open-market sales totaling 23,396 shares of common stock at prices ranging from $370.98 to $378.15. Following these transactions, he directly holds 880,313.9526 shares of Snap-on common stock, along with deferred stock units, performance units, restricted stock units and multiple stock option grants linked to additional common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 23,396 shares ($8,791,429)
Net Sell
27 txns
Insider
PINCHUK NICHOLAS T
Role
Chairman, President and CEO
Sold
23,396 shs ($8.79M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 33,750 | $0.00 | -- |
| Exercise | Common Stock | 33,750 | $168.70 | $5.69M |
| Sale | Common Stock | 640 | $371.2775 | $238K |
| Sale | Common Stock | 1,581 | $372.5299 | $589K |
| Sale | Common Stock | 704 | $374.1972 | $263K |
| Sale | Common Stock | 3,795 | $374.7676 | $1.42M |
| Sale | Common Stock | 6,850 | $375.8283 | $2.57M |
| Sale | Common Stock | 6,957 | $376.7744 | $2.62M |
| Sale | Common Stock | 2,480 | $377.5196 | $936K |
| Sale | Common Stock | 389 | $378.59 | $147K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Deferred Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 67,500 shares (Direct);
Common Stock — 880,313.953 shares (Direct);
Restricted Stock Units — 5,114 shares (Direct);
Performance Units — 15,340 shares (Direct);
Deferred Stock Units — 26,415.644 shares (Direct);
Common Stock — 871.871 shares (Indirect, By 401(k) Plan)
Footnotes (1)
- The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Includes 1.5164 shares acquired under a dividend reinvestment plan. This transaction was executed in multiple trades at prices ranging from $370.98 to $371.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $372.09 to $373.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $373.24 to $374.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $374.24 to $375.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $375.26 to $376.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $376.20 to $377.255. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $377.26 to $378.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This information is based on a plan statement dated March 31, 2026. Option fully vested. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. 1 for 1. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
Key Figures
Shares sold: 23,396 shares
Sale price range: $370.98–$378.15/share
Options exercised: 33,750 shares
+4 more
7 metrics
Shares sold
23,396 shares
Open-market sales of common stock on 2026-05-05
Sale price range
$370.98–$378.15/share
Weighted-average prices across multiple trades
Options exercised
33,750 shares
Common stock acquired via option exercise (Code M)
Option exercise price
$168.70/share
Exercise price for 33,750-share stock option
Direct holdings after transactions
880,313.9526 shares
Common stock directly held following reported trades
Largest remaining option grant
92,288 underlying shares at $161.18
Stock option expiring 2028-02-15
Deferred stock units
26,415.6442 units
Convertible into common stock on a 1-for-1 basis
Key Terms
Rule 10b5-1 Plan, Rule 16b-3 stock option, dividend reinvestment plan, performance units, +2 more
6 terms
Rule 10b5-1 Plan regulatory
"pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Rule 16b-3 stock option regulatory
"Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan"
dividend reinvestment plan financial
"Includes 1.5164 shares acquired under a dividend reinvestment plan"
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
performance units financial
"If the Company achieves certain goals over the 2024-2026 period, the performance units will vest"
Performance units are company awards that become valuable only if specified business targets are met; they typically convert into shares or cash when performance goals are achieved. Think of them like a conditional bonus that turns into stock only if the company hits agreed milestones, so they align managers’ incentives with shareholders’ interests and can affect future share count, executive pay expense, and investor returns.
restricted stock units financial
"The restricted stock units vest three years from the grant date on the date listed above"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred stock units financial
"Payment will be made in accordance with the reporting person's deferral election"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Snap-on (SNA) report for CEO Nicholas T. Pinchuk?
Snap-on reported that CEO Nicholas T. Pinchuk exercised options for 33,750 common shares at $168.70 and sold 23,396 shares in open-market trades on the same date. These activities were disclosed in a Form 4 insider filing with detailed pricing and share counts.
What stock options did the Snap-on (SNA) CEO exercise in this Form 4?
The CEO exercised stock options covering 33,750 shares of Snap-on common stock at an exercise price of $168.70 per share. A footnote states the option was fully vested and the exercise occurred pursuant to a Rule 10b5-1 trading plan adopted on November 3, 2025.
Were the Snap-on (SNA) CEO’s trades made under a Rule 10b5-1 plan?
Yes. Footnotes explain that the option exercise and related sale of underlying shares were executed pursuant to a Rule 10b5-1 Plan adopted on November 3, 2025. Such pre-arranged plans schedule trades in advance, helping separate trading activity from day-to-day discretionary decisions.